Avaxia Biologics Awarded Patent with Broad Coverage over Oral Anti-TNF ... Business Wire (press release) The patent covers milk-derived anti-TNF antibodies that are orally administered within a broad dose range for the treatment of inflammatory bowel disease (IBD). The claims also cover use of these antibodies for the treatment of IBD. Importantly, the ... |
